HQ Capital, established in 2015, is a global alternative investment manager headquartered in Germany. With over $12 billion in assets under management, the firm specializes in private equity and real estate. HQ Capital offers tailored investment solutions, leveraging its global network and local teams' expertise to meet clients' specific needs. The company's investment approach combines entrepreneurial spirit with a long-term focus on generating attractive returns. HQ Capital was formed by merging independent managers Auda, Real Estate Capital Partners, and Equita, bringing together over 25 years of experience in global private equity and U.S. real estate, as well as majority stakes acquisitions in small- and mid-sized European companies. The firm aligns its interests with clients by having its senior team and anchor investor, the Harald Quandt family, make significant financial contributions.
14/F Henley Building 5 Queen’s Road; Central, Hong Kong, China
Jacob Chiu
Managing Director, Head of Asian Investments and Member of the Executive Committee
Amit Dabas
Director
Michael Hu
Managing Director and Executive Committee Member
Patrick Knoefler
Managing Director and Executive Committee Member
Britta Lindhorst
Managing Director, Head of European Investments and Global Head of ESG / Impact
Oliver Schlümer
Director
Kenneth Ward-Smith
Managing Director
Stephen Wesson
Managing Director, General Partner, Executive Committee Member and Investment Committee Member
Benjamin Wilson
Managing Director and Executive Committee Member
Lily Young
Associate
1 past transactions
Interlace Medical
Series C in 2009
Interlace Medical, Inc. specializes in the design and development of medical devices aimed at interventional gynecologists for office-based procedures. The company focuses on treating gynecological diseases and conditions that have traditionally required surgical intervention in an operating room setting. Among its notable products is the MyoSure hysteroscopic tissue removal system, which is specifically designed for the removal of submucosal fibroids and polyps. Through its innovative solutions, Interlace Medical seeks to enhance the efficiency and effectiveness of gynecological treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.